Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR for Subsyndromal Bipolar Symptoms
NCT01197846Phase 3Completed
- Sponsor
- Centro de Investigación Biomédica en Red de Salud Mental
- Start
- Sep 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by Centro de Investigación Biomédica en Red de Salud Mental. Started Sep 2010; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01197846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197846.